Bovie Medical Corp. (BVX) Reports Stronger Q2 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts BVX Hot Sheet
Price: $6.48 --0%
Financial Fact:
Research and development: 682K
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Financial Fact:
Research and development: 682K
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Bovie Medical Corp. (NYSE: BVX) reported Q2 EPS of $0.02, versus $0.00 reported last year. Revenue for the quarter came in at $6.84 million, versus $5.9 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Beer Co. (SAM) Tops Q3 EPS by 15c; offers guidance
- GrafTech International Ltd. (EAF) Misses Q3 EPS by 39c
- Rithm Capital Corp. (RITM) Tops Q3 EPS by 6c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
